Skip to main content

Equibles does not estimate personal net worth.

About David Campbell

David Campbell is recorded as CEO and Board Member at Janux Therapeutics, Inc. (JANX). The newest filing on record that lists David Campbell as CEO and Board Member at Janux Therapeutics, Inc. (JANX) is dated April 28, 2023. The proxy statement of Janux Therapeutics, Inc. reports total compensation of $13,506,231 for David Campbell in fiscal 2025, including a base salary of $680,000. Disclosed compensation is on record for 6 fiscal years. Janux Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Janux Therapeutics, Inc. includes Ron Barrett, Ph.D. (Chairman), Tighe Reardon (CFO), Alana McNulty (Board Member) and 4 others.

Affiliation history

Company network

Leadership on record at Janux Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Janux Therapeutics, Inc. (JANX) $680,000 $13,506,231
2024 Janux Therapeutics, Inc. (JANX) $646,000 $8,974,873
2023 Janux Therapeutics, Inc. (JANX) $625,000 $4,193,269
2022 Janux Therapeutics, Inc. (JANX) $550,000 $6,001,878
2021 Janux Therapeutics, Inc. (JANX) $459,054 $8,410,429
2020 Janux Therapeutics, Inc. (JANX) $405,117 $811,682

Recent activity

No call appearances or filed executive changes recorded yet.